Your browser doesn't support javascript.
loading
Legionella co-infection in a patient with COVID-19.
Chaudhary, Rushil; Bondy, Lise; Zeeshan, Nikhath; Mrkobrada, Marko.
Afiliação
  • Chaudhary R; Department of Medicine, Western University, London, Ontario.
  • Bondy L; Department of Medicine, Western University, London, Ontario.
  • Zeeshan N; Division of Infectious Diseases, St. Joseph's Hospital, London, Ontario.
  • Mrkobrada M; Department of Medicine, Western University, London, Ontario.
J Assoc Med Microbiol Infect Dis Can ; 5(4): 261-263, 2020 Dec.
Article em En | MEDLINE | ID: mdl-36340054
ABSTRACT
We describe a case of an 80-year-old man with COVID-19 and Legionella bacterial co-infection who initially presented to hospital with fever, respiratory symptoms, and diarrhea with radiographic evidence of atypical infection. His initial nasopharyngeal swab was negative; however, a subsequent swab was positive. A Legionella urinary antigen test was positive for Legionella pneumophilia serogroup 1 antigen. Despite a low prevalence of bacterial co-infection in patients with COVID-19, a large number of patients receive antimicrobial therapy. Based on clinical context, a high index of suspicion is warranted for both bacterial and viral infectious processes during the COVID-19 pandemic; this will help to ensure that appropriate antimicrobial therapy is used.
Les auteurs décrivent le cas d'un homme de 80 ans co-infecté par la COVID-19 et la légionellose bactérienne qui a consulté à l'hôpital à cause de fièvre, de symptômes respiratoires et de diarrhée et dont la radiographie démontrait une infection atypique. Le premier écouvillon nasopharyngé a donné un résultat négatif, mais un écouvillon subséquent s'est révélé positif. Un test d'antigène urinaire des légionelles était positif à l'antigène Legionella pneumophilia du sérogroupe 1. Malgré une faible prévalence de co-infection bactérienne chez les patients atteints de la COVID-19, de nombreux patients reçoivent des antimicrobiens. D'après le contexte clinique, il faut faire preuve de vigilance à l'égard des processus bactériens et viraux pendant la pandémie de COVID-19 afin de s'assurer d'utiliser des antimicrobiens appropriés.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Assoc Med Microbiol Infect Dis Can Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Assoc Med Microbiol Infect Dis Can Ano de publicação: 2020 Tipo de documento: Article